Trademark Search in Canada

WEZENLA

View On IC.GC.CA

REGISTERED

on 12 Feb 2024

Last Applicant/ Owned by

AMGEN INC.

One Amgen Center DriveThousand Oaks, CA 91320-1799

Serial Number

2208179 filed on 7^th Sept 2022

Registration Number

TMA1221716 registered on 12^th Feb 2024

Registration expiry Date

12^th Feb 2034

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

WEZENLA

Trademark usage description

pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and di Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Classification kind code

Mark Details

Serial Number

2208179

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 12^th Feb 2024	Registration Pending
Submitted for opposition 42 on 22^nd Nov 2023	Advertised
Submitted for opposition 27 on 25^th Oct 2023	Approval Notice Sent
Submitted for opposition 26 on 25^th Oct 2023	Approved
Submitted for opposition 22 on 30^th May 2023	Search Recorded
Submitted for opposition 20 on 30^th May 2023	Examiner's First Report
Submitted for opposition 287 on 15^th Sept 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 7^th Sept 2022	Filed
Submitted for opposition 1 on 7^th Sept 2022	Created
Submitted for opposition 31 on 7^th Sept 2022	Formalized